1. Phase III Study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus melphalan and prednisone in myeloma;Abramson;Cancer Treat. Rep,1982
2. Oral melphalan kinetics;Alberts;Clin. Pharmacol. Ther,1979
3. Localized and indolent myeloma;Alexanian;Blood,1980
4. Prognostic factors in multiple myeloma;Alexanian;Cancer,1975
5. Remission maintenance therapy for multiple myeloma;Alexanian;Arch. Intern. Med,1975